Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-000585
Filing Date
2022-01-18
Accepted
2022-01-18 08:19:40
Documents
2
Period of Report
2022-01-14

Document Format Files

Seq Description Document Type Size
1 form3-01182022_050132.html 3  
1 form3-01182022_050132.xml 3 1659
2 ex24-01182022_050132.htm EX-24 6591
  Complete submission text file 0001415889-22-000585.txt   9676
Mailing Address C/O ONCOTHYREON INC. 2601 FOURTH AVE, SUITE 500 SEATTLE WA 98121
Business Address
HAUSMAN DIANA (Reporting) CIK: 0001563992 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40675 | Film No.: 22533694

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations